Lv3
210 积分 2020-11-12 加入
An update on antimicrobial selection and duration for intra-abdominal infections
24天前
已完结
How do I manage difficult-to-treat Pseudomonas aeruginosa infections? Key questions for today’s clinicians
24天前
已完结
Current Management Strategies of Difficult-to-Treat Resistant Pseudomonas aeruginosa Infections
24天前
已关闭
cirA promoter disruption and SHV-12 production contribute to cefiderocol resistance in carbapenem-resistant Klebsiella pneumoniae
24天前
已完结
Emergence of Carbapenem-Resistant Escherichia coli Coharboring bla CTX-M-199 and Penicillin-Binding Protein 3 Insertion Conferring Increased Aztreonam/Avibactam Resistance in South China
24天前
已完结
Aztreonam-Avibactam Resistance Due to Synergistic Interplay of ampC-Related Mutations in Carbapenem-Resistant Enterobacter spp
24天前
已关闭
Comparison of Ceftolozane-Tazobactam and Ceftazidime-Avibactam in the Treatment of Multidrug-Resistant/Difficult-to-Treat Resistant Pseudomonas aeruginosa Infections: A Systematic Review and Meta-analysis
24天前
已完结
Ceftazidime/Avibactam-Resistant Carbapenem-Resistant Klebsiella pneumoniae in China: A Nationwide Multicenter Study
24天前
已完结
Resistance development to new anti-Gram negatives antibiotics during treatment: geographical epidemiology and risk factors
2个月前
已关闭
Combating multidrug-resistant Klebsiella pneumoniae: current therapeutic regimens and future directions
2个月前
已关闭
皖公网安备34019202002308
